Loading…
Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix
Abstract Introduction Adenocarcinoma of the uterine cervix (AC) occurs in 15–20% of primary cervical neoplasias. Although some etiologic factors for squamous cell carcinoma are well defined, and its relationship with sexually transmitted disease as human papillomavirus (HPV) is established, we still...
Saved in:
Published in: | Gynecologic oncology 2007-04, Vol.105 (1), p.172-175 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c412t-8e21e9982fd73332995e21c65713036797f91bb03064b827968e39c28910dd583 |
---|---|
cites | |
container_end_page | 175 |
container_issue | 1 |
container_start_page | 172 |
container_title | Gynecologic oncology |
container_volume | 105 |
creator | Zereu, M Zettler, C.G Cambruzzi, E Zelmanowicz, A |
description | Abstract Introduction Adenocarcinoma of the uterine cervix (AC) occurs in 15–20% of primary cervical neoplasias. Although some etiologic factors for squamous cell carcinoma are well defined, and its relationship with sexually transmitted disease as human papillomavirus (HPV) is established, we still do not know about the causative factors of most of AC besides HPV infection. Objectives To determine the presence of herpes simplex virus type 2 (HSV-2) and Chlamydia trachomatis (CT) DNA in AC specimens, and its correlation with HPV infection. Methods 206 paraffin-embedded cases of AC were selected to DNA extraction. The specimens and the DNA were isolated. Samples were first screened for β-globin DNA sequences, and 67 cases were considered adequate to further analysis. In a previous analysis, DNA of HPV was identified in 79.4% of specimens included in this series (51% HPV 18 and 34% HPV 16).The local ethical committee approved the study. Results All samples were negative for HSV-2 DNA and CT DNA. Conclusions In our series HSV-2 DNA and CT DNA were not found to be integrated to the genome of adenocarcinoma of the uterine cervix and do not seem to be a co-factor for HPV on the etiology of this histologic subtype. |
doi_str_mv | 10.1016/j.ygyno.2006.11.006 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70305788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S009082580600922X</els_id><sourcerecordid>70305788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-8e21e9982fd73332995e21c65713036797f91bb03064b827968e39c28910dd583</originalsourceid><addsrcrecordid>eNqFkdGL1DAQxoMo3t7pXyBInnxrzSTbNnlQkEU94cAHFXyRkE2nbtY2qUm7XP9709sFwRefvmH4vpnkN4S8AFYCg_r1sVx-Lj6UnLG6BCizPCIbYKoqalmpx2TDmGKF5JW8ItcpHRljggF_Sq6gASnFlm_Ij1uMIyaa3DD2eE9PLs6JTsuIlFPjW7o79GZYWmfoFI09hMFMLlHnqWnRB2uidT43aejodEA6TxidR2oxntz9M_KkM33C5xe9Id8-vP-6uy3uPn_8tHt3V9gt8KmQyAGVkrxrGyEEV6rKHVtXDQgm6kY1nYL9Pr--3u4lb1QtUSjLpQLWtpUUN-TVee4Yw-8Z06QHlyz2vfEY5qSbHK0auRrF2WhjSClip8foBhMXDUyvVPVRP1DVK1UNoLPk1MvL-Hk_YPs3c8GYDW_OBsyfPDmMOlmH3mLrItpJt8H9Z8Hbf_K2d95Z0__CBdMxzNFnfhp04prpL-th17uyOlecfxd_AMnFnco</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70305788</pqid></control><display><type>article</type><title>Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix</title><source>ScienceDirect Journals</source><creator>Zereu, M ; Zettler, C.G ; Cambruzzi, E ; Zelmanowicz, A</creator><creatorcontrib>Zereu, M ; Zettler, C.G ; Cambruzzi, E ; Zelmanowicz, A</creatorcontrib><description>Abstract Introduction Adenocarcinoma of the uterine cervix (AC) occurs in 15–20% of primary cervical neoplasias. Although some etiologic factors for squamous cell carcinoma are well defined, and its relationship with sexually transmitted disease as human papillomavirus (HPV) is established, we still do not know about the causative factors of most of AC besides HPV infection. Objectives To determine the presence of herpes simplex virus type 2 (HSV-2) and Chlamydia trachomatis (CT) DNA in AC specimens, and its correlation with HPV infection. Methods 206 paraffin-embedded cases of AC were selected to DNA extraction. The specimens and the DNA were isolated. Samples were first screened for β-globin DNA sequences, and 67 cases were considered adequate to further analysis. In a previous analysis, DNA of HPV was identified in 79.4% of specimens included in this series (51% HPV 18 and 34% HPV 16).The local ethical committee approved the study. Results All samples were negative for HSV-2 DNA and CT DNA. Conclusions In our series HSV-2 DNA and CT DNA were not found to be integrated to the genome of adenocarcinoma of the uterine cervix and do not seem to be a co-factor for HPV on the etiology of this histologic subtype.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1016/j.ygyno.2006.11.006</identifier><identifier>PMID: 17188342</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenocarcinoma ; Adenocarcinoma - epidemiology ; Adenocarcinoma - microbiology ; Adenocarcinoma - virology ; Brazil - epidemiology ; Cervical cancer ; Chlamydia Infections - epidemiology ; Chlamydia Infections - virology ; Chlamydia trachomatis - genetics ; Chlamydia trachomatis - isolation & purification ; DNA, Bacterial - analysis ; DNA, Viral - analysis ; Etiology ; Female ; Hematology, Oncology and Palliative Medicine ; Herpes Genitalis - epidemiology ; Herpes Genitalis - microbiology ; Herpesvirus 2, Human - genetics ; Herpesvirus 2, Human - isolation & purification ; Humans ; Obstetrics and Gynecology ; Prevalence ; Sexually transmitted diseases ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - microbiology ; Uterine Cervical Neoplasms - virology</subject><ispartof>Gynecologic oncology, 2007-04, Vol.105 (1), p.172-175</ispartof><rights>Elsevier Inc.</rights><rights>2006 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-8e21e9982fd73332995e21c65713036797f91bb03064b827968e39c28910dd583</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17188342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zereu, M</creatorcontrib><creatorcontrib>Zettler, C.G</creatorcontrib><creatorcontrib>Cambruzzi, E</creatorcontrib><creatorcontrib>Zelmanowicz, A</creatorcontrib><title>Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Abstract Introduction Adenocarcinoma of the uterine cervix (AC) occurs in 15–20% of primary cervical neoplasias. Although some etiologic factors for squamous cell carcinoma are well defined, and its relationship with sexually transmitted disease as human papillomavirus (HPV) is established, we still do not know about the causative factors of most of AC besides HPV infection. Objectives To determine the presence of herpes simplex virus type 2 (HSV-2) and Chlamydia trachomatis (CT) DNA in AC specimens, and its correlation with HPV infection. Methods 206 paraffin-embedded cases of AC were selected to DNA extraction. The specimens and the DNA were isolated. Samples were first screened for β-globin DNA sequences, and 67 cases were considered adequate to further analysis. In a previous analysis, DNA of HPV was identified in 79.4% of specimens included in this series (51% HPV 18 and 34% HPV 16).The local ethical committee approved the study. Results All samples were negative for HSV-2 DNA and CT DNA. Conclusions In our series HSV-2 DNA and CT DNA were not found to be integrated to the genome of adenocarcinoma of the uterine cervix and do not seem to be a co-factor for HPV on the etiology of this histologic subtype.</description><subject>Adenocarcinoma</subject><subject>Adenocarcinoma - epidemiology</subject><subject>Adenocarcinoma - microbiology</subject><subject>Adenocarcinoma - virology</subject><subject>Brazil - epidemiology</subject><subject>Cervical cancer</subject><subject>Chlamydia Infections - epidemiology</subject><subject>Chlamydia Infections - virology</subject><subject>Chlamydia trachomatis - genetics</subject><subject>Chlamydia trachomatis - isolation & purification</subject><subject>DNA, Bacterial - analysis</subject><subject>DNA, Viral - analysis</subject><subject>Etiology</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Herpes Genitalis - epidemiology</subject><subject>Herpes Genitalis - microbiology</subject><subject>Herpesvirus 2, Human - genetics</subject><subject>Herpesvirus 2, Human - isolation & purification</subject><subject>Humans</subject><subject>Obstetrics and Gynecology</subject><subject>Prevalence</subject><subject>Sexually transmitted diseases</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - microbiology</subject><subject>Uterine Cervical Neoplasms - virology</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqFkdGL1DAQxoMo3t7pXyBInnxrzSTbNnlQkEU94cAHFXyRkE2nbtY2qUm7XP9709sFwRefvmH4vpnkN4S8AFYCg_r1sVx-Lj6UnLG6BCizPCIbYKoqalmpx2TDmGKF5JW8ItcpHRljggF_Sq6gASnFlm_Ij1uMIyaa3DD2eE9PLs6JTsuIlFPjW7o79GZYWmfoFI09hMFMLlHnqWnRB2uidT43aejodEA6TxidR2oxntz9M_KkM33C5xe9Id8-vP-6uy3uPn_8tHt3V9gt8KmQyAGVkrxrGyEEV6rKHVtXDQgm6kY1nYL9Pr--3u4lb1QtUSjLpQLWtpUUN-TVee4Yw-8Z06QHlyz2vfEY5qSbHK0auRrF2WhjSClip8foBhMXDUyvVPVRP1DVK1UNoLPk1MvL-Hk_YPs3c8GYDW_OBsyfPDmMOlmH3mLrItpJt8H9Z8Hbf_K2d95Z0__CBdMxzNFnfhp04prpL-th17uyOlecfxd_AMnFnco</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Zereu, M</creator><creator>Zettler, C.G</creator><creator>Cambruzzi, E</creator><creator>Zelmanowicz, A</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix</title><author>Zereu, M ; Zettler, C.G ; Cambruzzi, E ; Zelmanowicz, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-8e21e9982fd73332995e21c65713036797f91bb03064b827968e39c28910dd583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adenocarcinoma</topic><topic>Adenocarcinoma - epidemiology</topic><topic>Adenocarcinoma - microbiology</topic><topic>Adenocarcinoma - virology</topic><topic>Brazil - epidemiology</topic><topic>Cervical cancer</topic><topic>Chlamydia Infections - epidemiology</topic><topic>Chlamydia Infections - virology</topic><topic>Chlamydia trachomatis - genetics</topic><topic>Chlamydia trachomatis - isolation & purification</topic><topic>DNA, Bacterial - analysis</topic><topic>DNA, Viral - analysis</topic><topic>Etiology</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Herpes Genitalis - epidemiology</topic><topic>Herpes Genitalis - microbiology</topic><topic>Herpesvirus 2, Human - genetics</topic><topic>Herpesvirus 2, Human - isolation & purification</topic><topic>Humans</topic><topic>Obstetrics and Gynecology</topic><topic>Prevalence</topic><topic>Sexually transmitted diseases</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - microbiology</topic><topic>Uterine Cervical Neoplasms - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zereu, M</creatorcontrib><creatorcontrib>Zettler, C.G</creatorcontrib><creatorcontrib>Cambruzzi, E</creatorcontrib><creatorcontrib>Zelmanowicz, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zereu, M</au><au>Zettler, C.G</au><au>Cambruzzi, E</au><au>Zelmanowicz, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>105</volume><issue>1</issue><spage>172</spage><epage>175</epage><pages>172-175</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><abstract>Abstract Introduction Adenocarcinoma of the uterine cervix (AC) occurs in 15–20% of primary cervical neoplasias. Although some etiologic factors for squamous cell carcinoma are well defined, and its relationship with sexually transmitted disease as human papillomavirus (HPV) is established, we still do not know about the causative factors of most of AC besides HPV infection. Objectives To determine the presence of herpes simplex virus type 2 (HSV-2) and Chlamydia trachomatis (CT) DNA in AC specimens, and its correlation with HPV infection. Methods 206 paraffin-embedded cases of AC were selected to DNA extraction. The specimens and the DNA were isolated. Samples were first screened for β-globin DNA sequences, and 67 cases were considered adequate to further analysis. In a previous analysis, DNA of HPV was identified in 79.4% of specimens included in this series (51% HPV 18 and 34% HPV 16).The local ethical committee approved the study. Results All samples were negative for HSV-2 DNA and CT DNA. Conclusions In our series HSV-2 DNA and CT DNA were not found to be integrated to the genome of adenocarcinoma of the uterine cervix and do not seem to be a co-factor for HPV on the etiology of this histologic subtype.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17188342</pmid><doi>10.1016/j.ygyno.2006.11.006</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0090-8258 |
ispartof | Gynecologic oncology, 2007-04, Vol.105 (1), p.172-175 |
issn | 0090-8258 1095-6859 |
language | eng |
recordid | cdi_proquest_miscellaneous_70305788 |
source | ScienceDirect Journals |
subjects | Adenocarcinoma Adenocarcinoma - epidemiology Adenocarcinoma - microbiology Adenocarcinoma - virology Brazil - epidemiology Cervical cancer Chlamydia Infections - epidemiology Chlamydia Infections - virology Chlamydia trachomatis - genetics Chlamydia trachomatis - isolation & purification DNA, Bacterial - analysis DNA, Viral - analysis Etiology Female Hematology, Oncology and Palliative Medicine Herpes Genitalis - epidemiology Herpes Genitalis - microbiology Herpesvirus 2, Human - genetics Herpesvirus 2, Human - isolation & purification Humans Obstetrics and Gynecology Prevalence Sexually transmitted diseases Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - microbiology Uterine Cervical Neoplasms - virology |
title | Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T12%3A58%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Herpes%20simplex%20virus%20type%202%20and%20Chlamydia%20trachomatis%20in%20adenocarcinoma%20of%20the%20uterine%20cervix&rft.jtitle=Gynecologic%20oncology&rft.au=Zereu,%20M&rft.date=2007-04-01&rft.volume=105&rft.issue=1&rft.spage=172&rft.epage=175&rft.pages=172-175&rft.issn=0090-8258&rft.eissn=1095-6859&rft_id=info:doi/10.1016/j.ygyno.2006.11.006&rft_dat=%3Cproquest_cross%3E70305788%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c412t-8e21e9982fd73332995e21c65713036797f91bb03064b827968e39c28910dd583%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=70305788&rft_id=info:pmid/17188342&rfr_iscdi=true |